Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 5/20 | 0.56 |
| ▸ | CTSL | P07711 | 13/20 | 0.46 |
| ▸ | CTSS | P25774 | 12/20 | 0.46 |
| ▸ | CTSK | P43235 | 12/20 | 0.46 |
| ▸ | CTSB | P07858 | 10/20 | 0.46 |
| ▸ | CTSF | Q9UBX1 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290312 | 0.86 | CTSC (0.41) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL289590 | 0.85 | CTSC (0.38) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL2890791 | 0.84 | CTSC (0.77) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL290266 | 0.83 | CTSC (0.38) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL290666 | 0.82 | CTSC (0.38) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL290024 | 0.82 | CTSC (0.49) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL288986 | 0.82 | MMP1 (0.41) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL290246 | 0.81 | ALDH1A1 (0.41) | CTSCCTSLCTSSCTSKCTSB | |
| SCHEMBL290432 | 0.81 | CTSL (0.46) | CTSLCTSSCTSB | |
| SCHEMBL290579 | 0.80 | CTSL (0.47) | CTSCCTSLCTSSCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427445-A1 | SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 | AstraZeneca AB (SE) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010128324-A1 | SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 | ASTRAZENECA AB (SE) | 2010-11-11 | — | — | WO | disclosed |